Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

Share Price is delayed by 15 minutes
Get Live Data
3179.00    95.00 (3.08%)
Bid:
3186.00
Ask:
3188.00
Spread: 2.00 (0.063%)
Market Cap: £4.43b
CRDA Live PriceLast checked at - London Stock Exchange

Intraday Croda International Share Chart

Third Quarter Trading Statement

27 Oct 2011 07:00

RNS Number : 9104Q
Croda International PLC
27 October 2011
 



27 October 2011

 

Croda International Plc

 

Third Quarter Trading Statement

 

Commenting on trading for the quarter ended 30 September 2011, Martin Flower, Chairman of Croda International Plc, said:

 

"I am pleased to report good turnover and profit progress in the third quarter, driven by sales growth and margin improvement in our core businesses.

 

For the three months ended 30 September 2011, Group sales from continuing operations increased 5.1% to £265.6m (2010: £252.6m). In most business areas we saw an improving trend during the quarter.

 

Operating profit from continuing operations increased 18.3% to £57.6m (2009: £48.7m). Interest costs fell, resulting in continuing pre-tax profit increasing 20.8% to £57.4m (2010: £47.5m).

Year-to-date, the pre-tax profit from continuing operations is up 27.1% at £182.2m (2010: £143.4m).

 

Consumer Care continued to trade strongly in the third quarter, reporting a significant increase in sales (+13.6%) and operating profit (+30.8%) and improved margins versus the corresponding quarter in 2010. Sales and operating profits in all business areas within Consumer Care were well ahead of 2010.

 

Industrial Specialities turnover declined 3.5% against the tough comparatives of a particularly strong third quarter in 2010. The shortfall was in July, with sales in the rest of the period ahead of 2010. Operating profit was down 6.8% with a decrease in commodity and by-product profitability being partially mitigated by stronger performances elsewhere in the sector.

 

Net debt reduced by £15.5m to £237.8m in the quarter (2010: £240.7m) despite completing the £50m buyback programme in the period.

 

Croda continues to trade well and we expect to report further progress in the final quarter and into 2012."

 

For further information please contact:

 

Mike Humphrey

Group Chief Executive

01405 860551

Sean Christie

Group Finance Director

01405 860551

Charlie Armitstead

FTI Consulting

020 7269 7176

 

 

The company will host a conference call for analysts at 8.00am today.

 

Please dial +44 (0)1452 562 815 and quote "Croda International" to gain access to the call.

 

Additional Information

 

 

 

 

 

£m

Q3

9 months

2011

2010

2011

2010

Consumer Care

145.6

128.2

+13.6%

439.2

392.6

+11.9%

Industrial Specialities

120.0

124.4

-3.5%

386.0

371.9

+3.8%

Continuing turnover

265.6

252.6

+5.1%

825.2

764.5

+7.9%

Consumer Care

42.5

32.5

+30.8%

130.5

103.6

+26.0%

Industrial Specialities

15.1

16.2

-6.8%

52.4

45.6

+14.9%

Continuing operating profit

57.6

48.7

+18.3%

182.9

149.2

+22.6%

Operating margin

 

21.6%

 

19.3%

 

 

 

22.2%

 

19.5%

 

 

 

Interest

(0.2)

(1.2)

(0.7)

(5.8)

Continuing pre tax profit

57.4

47.5

+20.8%

182.2

143.4

+27.1%

 

 

 

 

Analysis of Q3 turnover uplift

Price/mix

+18.4%

Volume

-14.8%

Currency translation

+1.5%

Continuing turnover increase

+5.1%

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTMFBATMBJTBIB
Date   Source Headline
13th Nov 20174:01 pmRNSDirector/PDMR Shareholding
31st Oct 20177:00 amRNSTrading Update for the Third Quarter 2017
17th Oct 20179:23 amRNSAppointment of KPMG LLP as External Auditor
11th Oct 20174:59 pmRNSDirector/PDMR Shareholding
4th Oct 20172:36 pmRNSDirector/PDMR Shareholding
14th Sep 20171:50 pmRNSDirector/PDMR Shareholding
12th Sep 20172:17 pmRNSDirector/PDMR Shareholding
11th Aug 20172:20 pmRNSDirector/PDMR Shareholding
25th Jul 20177:00 amRNSResults for the six months ended 30 June 2017
11th Jul 20174:22 pmRNSDirector/PDMR Shareholding
11th Jul 20173:26 pmRNSDirector/PDMR Shareholding
14th Jun 20172:58 pmRNSDirector/PDMR Shareholding
2nd Jun 20175:45 pmRNSDirector/PDMR Shareholding
22nd May 20173:35 pmRNSHolding(s) in Company
19th May 20174:34 pmRNSHolding(s) in Company
18th May 20174:27 pmRNSHolding(s) in Company
15th May 20176:01 pmRNSHolding(s) in Company
15th May 20175:46 pmRNSDirector/PDMR Shareholding
15th May 20175:31 pmRNSDirector/PDMR Shareholding
15th May 20175:23 pmRNSDirector/PDMR Shareholding
15th May 20175:16 pmRNSDirector/PDMR Shareholding
15th May 20175:13 pmRNSDirector/PDMR Shareholding
15th May 20175:06 pmRNSDirector/PDMR Shareholding
15th May 20175:04 pmRNSDirector/PDMR Shareholding
15th May 20174:56 pmRNSDirector/PDMR Shareholding
15th May 20174:14 pmRNSDirector/PDMR Shareholding
15th May 20171:57 pmRNSTransaction in Own Shares
11th May 20173:01 pmRNSDirector/PDMR Shareholding
27th Apr 201710:09 amRNSResult of AGM
26th Apr 20177:00 amRNSTrading Update for the First Quarter 2017
11th Apr 20173:35 pmRNSDirector/PDMR Shareholding
23rd Mar 20173:27 pmRNSDirector/PDMR Shareholding
20th Mar 20175:45 pmRNSAnnual Financial Report
16th Mar 20173:45 pmRNSDirector/PDMR Shareholding
13th Mar 20172:20 pmRNSDirector/PDMR Shareholding
10th Mar 20174:39 pmRNSDirector/PDMR Shareholding
9th Mar 20174:53 pmRNSDirector/PDMR Shareholding
9th Mar 20179:50 amRNSDirector/PDMR Shareholding
28th Feb 20177:02 amRNSDr Keith Layden to become a Non-Executive Director
28th Feb 20177:00 amRNSResults for the year ended 31 December 2016
14th Feb 201710:37 amRNSDirector/PDMR Shareholding
11th Jan 20174:06 pmRNSDirector/PDMR Shareholding
20th Dec 20165:25 pmRNSDirector/PDMR Shareholding
13th Dec 20165:23 pmRNSDirector/PDMR Shareholding
24th Nov 20162:39 pmRNSHolding(s) in Company
21st Nov 20164:12 pmRNSDirector/PDMR Shareholding
11th Nov 20163:01 pmRNSDirector/PDMR Shareholding
3rd Nov 20167:00 amRNSTrading update for the third quarter of 2016
2nd Nov 20162:59 pmRNSHolding(s) in Company
1st Nov 201611:19 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.